Literature DB >> 11420884

Uridine 5'-diphosphoglucuronic acid (UDPGLcUA) in the human fetal liver, kidney and placenta.

M Cappiello1, L Giuliani, A Rane, G M Pacifici.   

Abstract

The endogenous concentration of uridine 5'-diphosphoglucoronic acid (UDPGLcUA), the endogenus substrate of UDP-glucuronosyltransferase, was measured in the human fetal and adult liver and kidney and in the placenta. The concentrations (mumol/Kg wet weight) of UDPGLcUA were 59.4 +/- 11.3 (fetal liver), 301 +/- 119 (adult liver), 11.9 +/- 3.2 (fetal kidney), 17.4 +/- 3.0 (adult kidney), 17.8 +/- 1.8 (mid-term placenta) and 17.0 +/- 1.7 (term placenta). UDPGLcUA is present in the human fetal liver at a concentration 5-fold lower than in the adult liver indicating a potential limiting factor for glucuronidation ind the human fetus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11420884     DOI: 10.1007/BF03192308

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  15 in total

1.  Dopamine sulphotransferase is better developed than p-nitrophenol sulphotransferase in the human fetus.

Authors:  M Cappiello; L Giuliani; A Rane; G M Pacifici
Journal:  Dev Pharmacol Ther       Date:  1991

2.  Development of the glucuronyltransferase and sulphotransferase towards 2-naphthol in human fetus.

Authors:  G M Pacifici; M Franchi; L Giuliani; A Rane
Journal:  Dev Pharmacol Ther       Date:  1989

Review 3.  Developmental aspects of drug conjugation, with special reference to glucuronidation.

Authors:  G J Dutton
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

4.  Development of multiple activities of UDP-glucuronyltransferase in human liver.

Authors:  J E Leakey; R Hume; B Burchell
Journal:  Biochem J       Date:  1987-05-01       Impact factor: 3.857

5.  Distribution of UDP-glucuronyltransferase in different human foetal tissues.

Authors:  G M Pacifici; A Rane
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

6.  Postnatal development of uridine diphosphate glucuronyltransferase activity towards bilirubin and 2-aminophenol in human liver.

Authors:  S Onishi; N Kawade; S Itoh; K Isobe; S Sugiyama
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857

7.  Development of human liver UDP-glucuronosyltransferases.

Authors:  B Burchell; M Coughtrie; M Jackson; D Harding; S Fournel-Gigleux; J Leakey; R Hume
Journal:  Dev Pharmacol Ther       Date:  1989

8.  Determination of hepatic uridine 5'-diphosphoglucuronic acid concentration by conjugation with diethylstilbestrol.

Authors:  J B Watkins; C D Klaassen
Journal:  J Pharmacol Methods       Date:  1982-03

9.  Morphine glucuronidation in human fetal and adult liver.

Authors:  G M Pacifici; J Säwe; L Kager; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

10.  The inadequacy of perinatal glucuronidation: immunoblot analysis of the developmental expression of individual UDP-glucuronosyltransferase isoenzymes in rat and human liver microsomes.

Authors:  M W Coughtrie; B Burchell; J E Leakey; R Hume
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

View more
  2 in total

Review 1.  Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants.

Authors:  Gian Maria Pacifici
Journal:  Paediatr Drugs       Date:  2012-08-01       Impact factor: 3.022

2.  Clinical pharmacology of furosemide in neonates: a review.

Authors:  Gian Maria Pacifici
Journal:  Pharmaceuticals (Basel)       Date:  2013-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.